Skip to content
Screener

Organogenesis Holdings Inc. ORGO Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Solventum logo
SolventumSOLV
$904M-1.4%
IAR
Integra LifeSciencesIART
MiMedx Group logo
MiMedx GroupMDXG
Axogen logo
AxogenAXGN
Anika Therapeutics logo
Anika TherapeuticsANIK
InfuSystem Holdings logo
InfuSystem HoldingsINFU

Other financials

Income statement

See full
Revenue$43.8M-56.7%
Gross profit$63.0M-22.5%
Operating income-$51.0M-305%
Net income-$96.3M-925%
EPS (diluted)-$0.77-670%

Balance sheet

See full
Cash & equivalents$46.1M-36.9%
Total debt$36.6M+19.2%
Total equity$148.3M-36.4%
Total assets$406.4M-11.9%

Cash flow

See full
Operating cash flow-$31.7M+3.7%
CapEx$1.1M-69.8%
Free cash flow-$32.8M+10.3%

Valuation

See full
Market cap$239.33M-59.1%
Enterprise value$229.8M-57.7%
P/S0.5×-0.8×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin-7.8%
Net margin-18.4%-20.8pp
FCF margin6.9%

Returns & leverage

See full
Return on equity-44.1%-48.0pp
Debt / equity0.2×+0.1×
Current ratio3.5×-0.4×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338049
Line itemJune 30, 2026December 31, 2025
Goodwill28,77228,772
Operating lease right-of-use assets, net49,91255,749
Deferred tax asset, net29,962
Other assets22,9259,203
Total assets$406,446$598,730
Liabilities, Redeemable Convertible Preferred Stock, and Stockholders’ Equity
Current liabilities:
Current portion of finance lease obligations$859$9,435

Item 1. Unaudited Condensed Consolidated Financial Statements.

FAQ

What is Organogenesis Holdings Inc.'s deferred tax assets and other non-current assets?
Organogenesis Holdings Inc. (ORGO) reported deferred tax assets and other non-current assets of $22.93M in Q2 2026.
How has Organogenesis Holdings Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Organogenesis Holdings Inc.'s deferred tax assets and other non-current assets increased by 162.6% year-over-year, from $8.73M to $22.93M.
What is the long-term trend for Organogenesis Holdings Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s deferred tax assets and other non-current assets has grown at a 68.9% compound annual growth rate (CAGR), from $670K to $9.2M.
What does deferred tax assets and other non-current assets mean?
Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Ask your AI about Organogenesis Holdings Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude